Flora Growth Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Flora Growth wird ein Gewinn- und Umsatzwachstum von 154.8% bzw. 8.1% pro Jahr prognostiziert, während der Gewinn pro Aktie um 156.6% pro Jahr wachsen soll.

Wichtige Informationen

137.4%

Wachstumsrate der Gewinne

142.1%

EPS-Wachstumsrate

Personal Products Gewinnwachstum	23.9%
Wachstumsrate der Einnahmen	8.7%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	15 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Sep 18

Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts

Aug 16

Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch

May 22

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Apr 04

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

Feb 17

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Dec 22

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Apr 17

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Dec 08

Flora Growth gains on deal to acquire No Cap Hemp assets

Sep 07

Elshad Garayev is the new finance chief of Flora Growth

Jul 11

Gewinn- und Umsatzwachstumsprognosen

NasdaqCM:FLGC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	78	4	N/A	-5	2
12/31/2024	68	-8	N/A	-8	2
6/30/2024	69	-13	-2	-2	N/A
3/31/2024	75	-48	-6	-5	N/A
12/31/2023	76	-47	-9	-8	N/A
9/30/2023	69	-50	-9	-8	N/A
6/30/2023	61	-57	-13	-13	N/A
3/31/2023	48	-42	-15	-14	N/A
12/31/2022	33	-46	-17	-16	N/A
9/30/2022	28	-48	-20	-17	N/A
6/30/2022	20	-45	-29	-26	N/A
3/31/2022	13	-26	-28	-25	N/A
12/31/2021	9	-21	-25	-21	N/A
9/30/2021	4	-15	-24	-22	N/A
6/30/2021	2	-17	-14	-12	N/A
3/31/2021	1	-15	-11	-10	N/A
12/31/2020	0	-14	-9	-8	N/A
6/30/2020	N/A	-4	-3	-3	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: FLGC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: FLGC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: FLGC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: FLGCDie Einnahmen des Unternehmens (8.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: FLGCDie Einnahmen des Unternehmens (8.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von FLGC in 3 Jahren voraussichtlich hoch sein wird

Flora Growth Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus revenue estimates fall by 12%

Consensus EPS estimates upgraded to US$0.41 loss, revenue downgraded

Forecast to breakeven in 2025

Consensus EPS estimates upgraded to US$0.03 loss

Consensus EPS estimates upgraded to US$0.21 loss

Price target decreased by 24% to US$1.33

Recent updates

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Flora Growth Corp. Announces Board Changes

Flora Growth Announces Update on Compliance with the Audit Committee Composition Requirements of Nasdaq Listing Rule 5605(c)(2)(A)

Consensus revenue estimates fall by 12%

Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp. (NasdaqCM:FLGC) acquired Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV:LFST) for CAD 0.87 million.

Flora Growth Corp., Annual General Meeting, Aug 14, 2024

High number of new and inexperienced directors

Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch

Consensus EPS estimates upgraded to US$0.41 loss, revenue downgraded

Forecast to breakeven in 2025

First quarter 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Shareholder dilution

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Flora Growth Corp. has completed a Follow-on Equity Offering in the amount of $3.23 million.

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

New major risk - Market cap size

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Flora Growth Corp. Receives Non-Compliance Notice From NASDAQ

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Revenue and earnings growth

Flora Growth Corp. Announces the Resignation of Juan Carlos Roa Gomez as Director

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. (NasdaqCM : FLGC) entered into a Sale and Purchase Agreement to acquire Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV : LFST) for $1.9 million.

Second quarter 2023 earnings: Revenues miss analyst expectations

Flora Growth Corp. Announces Resignation of Matthew Cohen as General Counsel

Flora Growth Corp. Appoints Dany Vaiman as Chief Financial Officer

Flora Growth Regains Compliance with Nasdaq Minimum Bid Requirement

Consensus EPS estimates upgraded to US$0.03 loss

Flora Growth Corp. Announces Board Appointments

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates upgraded to US$0.21 loss

Price target decreased by 24% to US$1.33

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Price target increased by 18% to US$2.92

Flora Growth Corp Provides Revenue Guidance for the Year 2023

Flora Growth Corp. Announces Executive Changes

Price target decreased to US$2.12

Forecast to breakeven in 2024

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Independent Director notifies of intention to sell stock

Third quarter 2022 earnings: EPS misses analyst expectations

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Price target decreased to US$2.67

High number of new and inexperienced directors

Flora Growth Corp. (NasdaqCM:FLGC) entered into a definitive agreement to acquire Franchise Global Health Inc. (TSXV:FGH) for CAD 32.2 million.

No longer forecast to breakeven

Flora Growth gains on deal to acquire No Cap Hemp assets

First half 2022 earnings released: US$0.42 loss per share (vs US$0.13 loss in 1H 2021)

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Flora Growth Corp. to Report First Half, 2022 Results on Aug 15, 2022

High number of new and inexperienced directors

Flora Growth Appoints Elshad Garayev as Chief Financial Officer

Elshad Garayev is the new finance chief of Flora Growth

Flora Growth Corp. Announces Board Appointments

Flora Growth Corp. (NasdaqCM:FLGC) announces an Equity Buyback for $5 million worth of its shares.

Flora Growth Corp., Annual General Meeting, Jul 05, 2022

Flora Growth Corp. (NasdaqCM:FLGC) and Annabelle Manalo-Morgan agreed to acquire Masaya Medical, Inc.

Flora Growth Corp. Reiterates Earnings Guidance for the Full Year 2022

Flora Growth Corp. to Report Fiscal Year 2021 Results on May 10, 2022

Flora Growth Corp. Announces Launch of New Skincare Line Under Its Brand, MIND Naturals

High number of new and inexperienced directors

Flora Growth Corp. Appoints Jessie Casner as Chief Marketing Officer to Drive Growth of Brand Portfolio

Flora Growth Registers First-Ever Cannabinoid Food and Beverage Products with Colombian-FDA